Cellyan Biotechnology Announces 1-for-20 Reverse Stock Split Effective Oct. 26

Bitget2026/10/21 12:02

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Cellyan Biotechnology expects a 1-for-20 reverse stock split of Class A and Class B ordinary shares effective October 26, 2026.
Split-adjusted trading in Class A ordinary shares will begin on Nasdaq at the market open that day under ticker HKPD.
The consolidation aims to regain compliance with the Nasdaq Capital Market’s minimum bid price requirement for continued listing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellyan Biotechnology Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-111190), on October 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Cellyan Biotechnology Announces 1-for-20 Reverse Stock Split Effective Oct. 26

You may also like

Crypto prices